Ajanta Pharma Ltd

AJANTPHARM
Pharmaceuticals
โ‚น 2,469
Price
โ‚น 30,853
Market Cap
Large Cap
33.18
P/E Ratio

๐Ÿ“Š Score Snapshot

20.0 / 25
Performance
23.67 / 25
Valuation
1.87 / 20
Growth
7.0 / 30
Profitability
52.54 / 100
Risky

๐Ÿข Company Overview

โณ Loading company overview...

๐Ÿค– CARL Insights

โณ Loading CARL insights...

๐Ÿ“ˆ Net Profit (Yearly)

๐Ÿ“Š Sales (Yearly)

๐Ÿ“‰ Quarterly Sales Trend

๐Ÿ“‰ Quarterly Net Profit

๐Ÿ“ˆ Yearly Ratios

Metric Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Adj Cash EBITDA 1,528 1,145 958.00 846.00 812.00 653.00 504.00 429.00
Adj Cash EBITDA Margin 32.32 28.41 25.67 27.55 27.80 28.15 24.69 21.57
Adj Cash EBITDA To EBITDA 1.13 0.92 1.08 0.81 0.80 0.84 0.86 0.63
Adj Cash EPS 88.36 56.52 50.64 39.95 34.51 26.12 23.22 16.28
Adj Cash PAT 1,104 724.06 648.69 512.22 447.91 342.18 304.00 215.00
Adj Cash PAT To PAT 1.19 0.88 1.12 0.72 0.68 0.74 0.79 0.46
Adj Cash PE 29.73 38.95 23.65 29.64 33.91 32.87 29.38 57.10
Adj EPS 74.03 64.33 45.41 55.56 50.61 35.51 29.56 35.50
Adj EV To Cash EBITDA 21.01 23.97 15.30 17.55 18.14 17.05 17.44 27.96
Adj EV To EBITDA 23.79 22.05 16.45 14.20 14.43 14.35 14.97 17.56
Adj Number Of Shares 12.49 12.81 12.81 12.82 12.98 13.10 13.09 13.21
Adj PE 35.51 34.18 26.35 21.32 23.07 24.23 23.08 26.17
Adj Peg 2.36 0.82 - 2.18 0.54 1.20 - -
Bvps 303.44 278.45 264.48 254.60 230.74 198.40 171.58 154.58
Cash Conversion Cycle 246.00 233.00 240.00 315.00 315.00 184.00 282.00 170.00
Cash ROCE 25.23 20.18 18.62 16.35 14.23 9.01 1.61 0.66
Cash Roic 28.39 23.53 20.73 15.57 15.80 7.16 0.99 -0.40
Cash Revenue 4,728 4,030 3,732 3,071 2,921 2,320 2,041 1,989
Cash Revenue To Revenue 1.02 0.96 1.00 0.92 1.01 0.90 0.99 0.94
Dio 308.00 283.00 283.00 347.00 434.00 276.00 415.00 315.00
Dpo 155.00 159.00 147.00 143.00 212.00 202.00 214.00 224.00
Dso 93.00 108.00 103.00 111.00 93.00 109.00 82.00 79.00
Dividend Yield 1.07 2.31 0.57 0.52 0.56 0.99 0.87 -
EV 32,098 27,447 14,657 14,849 14,733 11,137 8,787 11,995
EV To EBITDA 23.90 22.24 16.30 14.18 14.49 14.28 14.97 17.56
EV To Fcff 36.62 41.87 26.17 34.71 37.67 70.30 464.20 -
Fcfe 931.64 720.06 606.69 506.22 360.91 219.18 68.00 13.00
Fcfe Margin 19.70 17.87 16.26 16.48 12.36 9.45 3.33 0.65
Fcfe To Adj PAT 1.01 0.87 1.04 0.71 0.55 0.47 0.18 0.03
Fcff 876.53 655.60 560.15 427.80 391.13 158.42 18.93 -6.07
Fcff Margin 18.54 16.27 15.01 13.93 13.39 6.83 0.93 -0.31
Fcff To NOPAT 1.01 0.86 1.05 0.67 0.61 0.38 0.05 -0.01
Market Cap 32,691 27,892 15,487 15,183 15,088 11,346 8,930 12,276
PB 8.63 7.82 4.57 4.65 5.04 4.37 3.98 6.01
PE 35.52 34.18 26.34 21.29 23.07 24.24 23.08 26.18
Peg 2.27 0.88 - 2.04 0.56 1.16 - -
PS 7.03 6.63 4.14 4.54 5.22 4.38 4.35 5.77
ROCE 25.07 23.14 17.87 22.87 23.07 19.34 17.93 25.97
ROE 25.14 23.70 17.49 22.76 23.49 19.20 18.05 25.98
Roic 28.20 27.26 19.81 23.07 25.98 18.72 19.44 29.55
Share Price 2,617 2,177 1,209 1,184 1,162 866.07 682.23 929.27

๐Ÿ“Š Quarterly Results

Metric Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Sales 1,354 1,303 1,170 1,146 1,187 1,145 1,054 1,105 1,028 1,021 882.00 972.00 938.00 951.00
Interest 3.00 5.00 6.00 8.00 6.00 1.00 2.00 2.00 2.00 1.00 1.00 3.00 1.00 1.00
Expenses - 1,026 951.00 873.00 825.00 875.00 815.00 776.00 791.00 738.00 750.00 732.00 802.00 742.00 729.00
Other Income - 59.00 26.33 18.11 30.44 19.48 26.47 35.50 13.59 21.33 31.75 36.83 34.93 40.35 32.76
Depreciation 43.00 41.00 40.00 36.00 34.00 34.00 34.00 34.00 34.00 33.00 33.00 33.00 33.00 32.00
Profit Before Tax 341.00 331.00 269.00 307.00 290.00 322.00 278.00 291.00 276.00 269.00 152.00 168.00 203.00 222.00
Tax % 23.75 22.96 16.36 24.10 25.52 23.60 26.98 27.84 29.35 22.68 19.74 19.64 22.66 21.17
Net Profit - 260.00 255.00 225.00 233.00 216.00 246.00 203.00 210.00 195.00 208.00 122.00 135.00 157.00 175.00
Profit Excl Exceptional 260.00 255.00 225.00 233.00 216.00 246.00 203.00 210.00 195.00 208.00 122.00 135.00 157.00 175.00
Profit For PE 260.00 255.00 225.00 233.00 216.00 246.00 203.00 210.00 195.00 208.00 122.00 135.00 157.00 175.00
Profit For EPS 260.00 255.00 225.00 233.00 216.00 246.00 203.00 210.00 195.00 208.00 122.00 135.00 157.00 175.00
EPS In Rs 20.83 20.44 18.03 18.64 17.33 19.68 15.82 16.39 15.24 16.24 9.54 10.50 12.22 13.63
PAT Margin % 19.20 19.57 19.23 20.33 18.20 21.48 19.26 19.00 18.97 20.37 13.83 13.89 16.74 18.40
PBT Margin 25.18 25.40 22.99 26.79 24.43 28.12 26.38 26.33 26.85 26.35 17.23 17.28 21.64 23.34
Tax 81.00 76.00 44.00 74.00 74.00 76.00 75.00 81.00 81.00 61.00 30.00 33.00 46.00 47.00
Yoy Profit Growth % 20.00 4.00 11.00 11.00 11.00 18.00 66.00 56.00 25.00 19.00 -19.00 -30.00 -20.00 -
Adj Ebit 344.00 337.33 275.11 315.44 297.48 322.47 279.50 293.59 277.33 269.75 153.83 171.93 203.35 222.76
Adj EBITDA 387.00 378.33 315.11 351.44 331.48 356.47 313.50 327.59 311.33 302.75 186.83 204.93 236.35 254.76
Adj EBITDA Margin 28.58 29.04 26.93 30.67 27.93 31.13 29.74 29.65 30.29 29.65 21.18 21.08 25.20 26.79
Adj Ebit Margin 25.41 25.89 23.51 27.53 25.06 28.16 26.52 26.57 26.98 26.42 17.44 17.69 21.68 23.42
Adj PAT 260.00 255.00 225.00 233.00 216.00 246.00 203.00 210.00 195.00 208.00 122.00 135.00 157.00 175.00
Adj PAT Margin 19.20 19.57 19.23 20.33 18.20 21.48 19.26 19.00 18.97 20.37 13.83 13.89 16.74 18.40
Ebit 344.00 337.33 275.11 315.44 297.48 322.47 279.50 293.59 277.33 269.75 153.83 171.93 203.35 222.76
EBITDA 387.00 378.33 315.11 351.44 331.48 356.47 313.50 327.59 311.33 302.75 186.83 204.93 236.35 254.76
EBITDA Margin 28.58 29.04 26.93 30.67 27.93 31.13 29.74 29.65 30.29 29.65 21.18 21.08 25.20 26.79
Ebit Margin 25.41 25.89 23.51 27.53 25.06 28.16 26.52 26.57 26.98 26.42 17.44 17.69 21.68 23.42
NOPAT 217.31 239.59 214.95 216.31 207.05 226.14 178.17 202.05 180.86 184.02 93.90 110.09 126.06 149.78
NOPAT Margin 16.05 18.39 18.37 18.88 17.44 19.75 16.90 18.29 17.59 18.02 10.65 11.33 13.44 15.75
Operating Profit 285.00 311.00 257.00 285.00 278.00 296.00 244.00 280.00 256.00 238.00 117.00 137.00 163.00 190.00
Operating Profit Margin 21.05 23.87 21.97 24.87 23.42 25.85 23.15 25.34 24.90 23.31 13.27 14.09 17.38 19.98

๐Ÿ’ฐ Profit & Loss

Metric Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Mar 2014
Sales 4,648 4,209 3,743 3,341 2,890 2,588 2,055 2,126 1,983 1,749 1,474 1,208
Interest 21.00 7.00 6.00 10.00 8.00 12.00 1.00 - 1.00 5.00 6.00 9.00
Expenses - 3,379 3,037 2,934 2,408 1,889 1,904 1,489 1,467 1,292 1,155 968.00 840.00
Other Income - 80.00 73.00 82.00 113.00 20.00 92.00 21.00 24.00 24.00 16.00 16.00 14.00
Exceptional Items 6.00 11.00 -8.00 -1.00 4.00 -4.00 - - -4.00 -1.00 -7.00 -
Depreciation 144.00 135.00 131.00 125.00 116.00 96.00 72.00 60.00 61.00 44.00 52.00 44.00
Profit Before Tax 1,189 1,114 745.00 909.00 900.00 664.00 514.00 623.00 648.00 559.00 456.00 330.00
Tax % 22.62 26.75 21.07 21.56 27.33 29.52 24.71 24.72 21.76 25.58 32.02 29.09
Net Profit - 920.00 816.00 588.00 713.00 654.00 468.00 387.00 469.00 507.00 416.00 310.00 234.00
Exceptional Items At 4.00 8.00 -6.00 -1.00 3.00 -3.00 - - -3.00 -1.00 -5.00 -
Profit Excl Exceptional 916.00 808.00 594.00 713.00 651.00 471.00 387.00 469.00 510.00 417.00 315.00 234.00
Profit For PE 916.00 808.00 594.00 713.00 651.00 471.00 387.00 469.00 510.00 417.00 315.00 234.00
Profit For EPS 920.00 816.00 588.00 713.00 654.00 468.00 387.00 469.00 507.00 416.00 310.00 234.00
EPS In Rs 73.68 63.70 45.89 55.63 50.38 35.73 29.56 35.50 38.40 31.49 23.47 17.75
Dividend Payout % 38.00 79.00 15.00 11.00 13.00 24.00 20.00 - 23.00 17.00 17.00 15.00
PAT Margin % 19.79 19.39 15.71 21.34 22.63 18.08 18.83 22.06 25.57 23.79 21.03 19.37
PBT Margin 25.58 26.47 19.90 27.21 31.14 25.66 25.01 29.30 32.68 31.96 30.94 27.32
Tax 269.00 298.00 157.00 196.00 246.00 196.00 127.00 154.00 141.00 143.00 146.00 96.00
Adj Ebit 1,205 1,110 760.00 921.00 905.00 680.00 515.00 623.00 654.00 566.00 470.00 338.00
Adj EBITDA 1,349 1,245 891.00 1,046 1,021 776.00 587.00 683.00 715.00 610.00 522.00 382.00
Adj EBITDA Margin 29.02 29.58 23.80 31.31 35.33 29.98 28.56 32.13 36.06 34.88 35.41 31.62
Adj Ebit Margin 25.93 26.37 20.30 27.57 31.31 26.28 25.06 29.30 32.98 32.36 31.89 27.98
Adj PAT 924.64 824.06 581.69 712.22 656.91 465.18 387.00 469.00 503.87 415.26 305.24 234.00
Adj PAT Margin 19.89 19.58 15.54 21.32 22.73 17.97 18.83 22.06 25.41 23.74 20.71 19.37
Ebit 1,199 1,099 768.00 922.00 901.00 684.00 515.00 623.00 658.00 567.00 477.00 338.00
EBITDA 1,343 1,234 899.00 1,047 1,017 780.00 587.00 683.00 719.00 611.00 529.00 382.00
EBITDA Margin 28.89 29.32 24.02 31.34 35.19 30.14 28.56 32.13 36.26 34.93 35.89 31.62
Ebit Margin 25.80 26.11 20.52 27.60 31.18 26.43 25.06 29.30 33.18 32.42 32.36 27.98
NOPAT 870.53 759.60 535.15 633.80 643.13 414.42 371.93 450.93 492.91 409.31 308.63 229.75
NOPAT Margin 18.73 18.05 14.30 18.97 22.25 16.01 18.10 21.21 24.86 23.40 20.94 19.02
Operating Profit 1,125 1,037 678.00 808.00 885.00 588.00 494.00 599.00 630.00 550.00 454.00 324.00
Operating Profit Margin 24.20 24.64 18.11 24.18 30.62 22.72 24.04 28.17 31.77 31.45 30.80 26.82

๐Ÿฆ Balance Sheet

Metric Sep 2025 Mar 2025 Sep 2024 Mar 2024 Sep 2023 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Accumulated Depreciation - 1,039 - 910.00 - 786.00 706.00 600.00 504.00 415.00
Advance From Customers - 74.00 - 39.00 - 10.00 52.00 21.00 15.00 4.00
Average Capital Employed 4,135 3,720 3,612 3,513 - 3,356 3,158 2,850 2,478 2,162
Average Invested Capital 3,250 3,088 2,964 2,786 - 2,702 2,748 2,476 2,214 1,913
Average Total Assets 5,231 4,717 4,612 4,556 - 4,291 3,864 3,511 2,978 2,545
Average Total Equity 3,996 3,678 3,580 3,478 - 3,326 3,130 2,797 2,422 2,144
Cwip 146.00 176.00 349.00 256.00 205.00 209.00 153.00 108.00 132.00 262.00
Capital Employed 4,561 3,837 3,709 3,603 3,515 3,423 3,290 3,027 2,674 2,281
Cash Equivalents 91.00 176.00 65.00 131.00 263.00 331.00 212.00 210.00 205.00 101.00
Fixed Assets 1,873 1,762 1,451 1,479 1,485 1,496 1,512 1,541 1,472 1,178
Gross Block - 2,801 - 2,389 - 2,283 2,218 2,141 1,976 1,593
Inventory 812.00 904.00 846.00 828.00 786.00 816.00 791.00 766.00 496.00 436.00
Invested Capital 3,587 3,116 2,913 3,059 3,016 2,513 2,891 2,604 2,347 2,081
Investments 874.00 464.00 702.00 349.00 238.00 535.00 147.00 176.00 79.00 78.00
Lease Liabilities 44.00 44.83 30.37 33.79 32.11 34.20 23.12 29.67 29.28 -
Loans N Advances 10.00 81.00 29.00 98.00 - 61.00 46.00 44.00 51.00 34.00
Long Term Borrowings - - - - - 1.25 1.64 1.60 0.74 0.66
Net Debt -719.00 -593.00 -734.00 -445.00 -468.00 -830.00 -334.00 -355.00 -209.00 -143.00
Net Working Capital 1,568 1,178 1,113 1,324 1,326 808.00 1,226 955.00 743.00 641.00
Other Asset Items 419.00 158.00 332.00 142.00 294.00 77.00 119.00 145.00 82.00 117.00
Other Borrowings - - - - - - 0.27 0.09 2.09 1.96
Other Liability Items 681.00 539.00 660.00 425.00 557.00 726.00 331.00 307.00 242.00 154.00
Reserves 4,290 3,765 3,652 3,542 3,457 3,363 3,247 2,978 2,581 2,228
Share Capital 25.00 25.00 25.00 25.00 25.00 25.00 17.00 17.00 18.00 18.00
Short Term Borrowings 202.00 2.59 2.42 1.49 0.91 0.18 - - 42.85 33.34
Short Term Loans And Advances - - - 34.00 23.00 17.00 6.00 8.00 9.00 12.00
Total Assets 5,672 4,904 4,790 4,530 4,433 4,582 4,000 3,729 3,293 2,664
Total Borrowings 246.00 47.00 33.00 35.00 33.00 36.00 25.00 31.00 75.00 36.00
Total Equity 4,315 3,790 3,677 3,567 3,482 3,388 3,264 2,995 2,599 2,246
Total Equity And Liabilities 5,672 4,904 4,790 4,530 4,433 4,582 4,000 3,729 3,293 2,664
Total Liabilities 1,357 1,114 1,113 963.00 951.00 1,194 736.00 734.00 694.00 418.00
Trade Payables 430.00 454.00 421.00 463.00 361.00 423.00 327.00 374.00 362.00 225.00
Trade Receivables 1,448 1,183 1,016 1,247 1,141 1,057 1,020 738.00 775.00 459.00

๐Ÿ’ต Cash Flows

Metric Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Cash From Financing Activity -733.00 -1,051 -108.00 -460.00 -318.00 -129.00 -147.00 -
Cash From Investing Activity -377.00 65.00 -560.00 -74.00 -282.00 -224.00 -223.00 -256.00
Cash From Operating Activity 1,157 785.00 792.00 562.00 576.00 457.00 375.00 281.00
Cash Paid For Loan Advances - - -11.00 2.00 1.00 5.00 - -
Cash Paid For Purchase Of Fixed Assets -318.00 -152.00 -174.00 -149.00 -172.00 -239.00 -343.00 -263.00
Cash Paid For Purchase Of Investments -2,767 -2,080 -1,667 -1,063 -742.00 -278.00 -275.00 -233.00
Cash Paid For Repayment Of Borrowings - - - - -44.00 - - -
Cash Received From Borrowings 1.00 - - - - 10.00 34.00 1.00
Cash Received From Sale Of Fixed Assets 1.00 13.00 1.00 18.00 13.00 10.00 1.00 -
Cash Received From Sale Of Investments 2,663 2,257 1,276 1,092 646.00 276.00 392.00 236.00
Change In Inventory -75.00 -12.00 -22.00 -26.00 -271.00 -59.00 -85.00 -139.00
Change In Other Working Capital Items 181.00 51.00 14.00 141.00 19.00 67.00 41.00 -51.00
Change In Payables -8.00 41.00 97.00 -48.00 11.00 133.00 -24.00 72.00
Change In Receivables 80.00 -179.00 -11.00 -270.00 31.00 -268.00 -14.00 -137.00
Change In Working Capital 179.00 -100.00 67.00 -200.00 -209.00 -123.00 -83.00 -254.00
Direct Taxes Paid -323.00 -312.00 -151.00 -239.00 -230.00 -155.00 -118.00 -140.00
Dividends Paid -349.00 -642.00 -90.00 -82.00 -83.00 -113.00 -79.00 -
Interest Paid -17.00 -4.00 -2.00 -7.00 -5.00 -7.00 -1.00 -
Investment Income 44.00 - - - - - - -
Net Cash Flow 47.00 -201.00 124.00 28.00 -24.00 104.00 4.00 25.00
Other Cash Financing Items Paid -368.00 -405.00 -15.00 -371.00 -187.00 -17.00 -101.00 -
Other Cash Investing Items Paid 44.00 27.00 5.00 28.00 -27.00 6.00 2.00 3.00
Profit From Operations 1,301 1,197 877.00 1,001 1,015 735.00 576.00 675.00

๐Ÿงพ Shareholding Pattern

Nse Code Date Promoters Fii Dii Public Others
Ajantpharm 2025-09-30 - 8.53 17.90 7.32 0.00
Ajantpharm 2025-06-30 - 8.86 17.50 7.38 0.00
Ajantpharm 2025-03-31 - 8.86 17.48 7.38 0.00
Ajantpharm 2024-12-31 - 9.26 17.02 7.45 0.00
๐Ÿ’ฌ
Stock Chat